Skip to main content

Table 1 Glycated hemoglobin, neuropathy symptom and disability scores, and autonomic nervous system assessment among diabetic neuropathy patients (group I), diabetic patients without neuropathy (group II) and healthy control (group III)

From: Sleep disturbances in diabetic peripheral neuropathy patients: a clinical and polysomnographic study

Ā 

Group I

Group II

Group III

ANOVA

Range

Meanā€‰Ā±ā€‰SD

Range

Meanā€‰Ā±ā€‰SD

Range

Meanā€‰Ā±ā€‰SD

f value

p value

HBA1c (%)

6.7ā€“11.5

8.33Ā Ā±Ā 1.48

6.8ā€“8.5

7.57Ā Ā±Ā 0.53

5.5ā€“6.3

5.90Ā Ā±Ā 0.26

16.18

<ā€‰0.0001*

NSS

5ā€“9

7.1Ā Ā±Ā 1.48

1ā€“4

2Ā Ā±Ā 1.05

1ā€“3

1.6Ā Ā±Ā 0.69

92.73

<ā€‰0.0001*

NDS

6ā€“10

8.05Ā Ā±Ā 1.5

1ā€“4

2.1Ā Ā±Ā 0.99

1ā€“2

1.5Ā Ā±Ā 0.52

133.6

<ā€‰0.0001*

PSH

10ā€“40

23.3Ā Ā±Ā 11.2

5ā€“13

8.8Ā Ā±Ā 2.48

5ā€“10

6.7Ā Ā±Ā 1.49

18.46

<ā€‰0.0001*

Postural tachycardia

13ā€“39

23.8Ā Ā±Ā 8.03

13ā€“26

14.3Ā Ā±Ā 4.5

11ā€“21

15.3Ā Ā±Ā 2.98

6.31

0.0044*

HRDB

5ā€“16

10.7Ā Ā±Ā 3.4

9ā€“18

13.1Ā Ā±Ā 2.76

9ā€“18

13.9Ā Ā±Ā 2.88

4.08

0.025*

HRV

1.1ā€“1.3

1.25Ā Ā±Ā 0.06

1.3ā€“1.4

1.29Ā Ā±Ā 0.04

1.2ā€“1.4

1.29Ā Ā±Ā 0.04

3.40

0.51

  1. HRDB heart rate response to deep breath, HRV heart rate response to Valsalva, NDS neuropathy disability score, NSS neuropathy symptom score, PSH postural systolic hypotension
  2. *Significant